Nykode
Trygve Lauvdal is an Investment Director with RASMUSSENGRUPPEN AS, a major shareholder of the Company. Prior to joining RASMUSSENGRUPPEN AS, he worked as an equity analyst with DNB Markets and as product manager with ABB. He has held several board positions with Norwegian companies. He holds a Ph.D. in Engineering Cybernetics from the Norwegian University of Science and Technology (NTNU).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nykode
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies